 | « Reply #88 on: December 05, 2009, 03:44:16 PM » |  Quote |
Evidence abounds of the deadly D225G mutation mixing with the Tamiflu resistance of H274Y spelling trouble for the near future.
WHO in Denial on Tamiflu Resistance and RBD Changes
http://www.recombinomics.com/News/12050902/H274Y_D225G_Denial.html
WHO in Denial on Tamiflu Resistance and RBD Changes
http://www.recombinomics.com/News/12050902/H274Y_D225G_Denial.html
Quote
The denial of the explosion of H274Y as well as the association of D225G in fatal lung infections raises concerns that these events are being portrayed in an overly optimistic light. Although cases are declining in many parts of the world, these genetic changes in transmission and ant-viral resistance raise concerns that the next wave will be markedly more virulent and difficult to treat at a time when the efficiency of anti-virals and the utility of the vaccine target are in a decline.
No comments:
Post a Comment